Session Information

Filter Results:

Show Only CME Accredited Sessions

  • +

    JCSE 01 - Joint IASLC/CSCO/CAALC Session: Immunotherapy for Management of Lung Cancer: Ongoing Research from East and West

    • 07:30 - 11:30
    • 10/15/2017
    • Location: F203 (Annex Hall)
    • Type: Joint Session IASLC/CSCO/CAALC
    • Track: Immunology and Immunotherapy
    • +

      JCSE 01.12 - A Phase II Study of Fruquintinib in Combination with Gefitinib in Stage IIIb/IV NSCLC Patients Harboring EGFR Activating Mutations

      10:35 - 10:50  |  Presenter: Shun Lu  |  Author(s): J. Zhou, X. Niu, M. Chen, Y. Hua, W. Su

      • Abstract

      Loading...

  • +

    P3.01 - Advanced NSCLC

    • 09:30 - 16:00
    • 10/18/2017
    • Location: Exhibit Hall (Hall B + C)
    • Type: Poster Session with Presenters Present
    • Track: Advanced NSCLC
    • +

      P3.01-070 - A Phase II Study of Fruquintinib in Combination with Gefitinib in Stage IIIb/IV NSCLC Patients Harboring EGFR Activating Mutations

      09:30 - 09:30  |  Presenter: Shun Lu  |  Author(s): J. Zhou, X. Niu, M. Chen, Y. Hua, W. Su

      • Abstract

      Loading...